crovalimab-akkz

crovalimab-akkz (PIASKY) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.

PIASKY is a marketed brand name for crovalimab-akkz. Check FDA Drugs@FDA for the current US label holder and prescribing information.

crovalimab-akkz has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.